What do sources say about finasteride during a cycle?
| Product | Label use | Label dose |
|---|---|---|
| Propecia | Male pattern hair loss, men only | One tablet (1 mg) taken once daily1 |
| Proscar | Symptomatic BPH in men with an enlarged prostate | One tablet (5 mg) taken once a day, alone or with doxazosin2 |
The Propecia and Proscar labels give finasteride as one 1 mg tablet once daily for hair loss or one 5 mg tablet once a day for BPH, and the searches found no label or trial of finasteride during a bodybuilding or performance steroid cycle; the closest is Borst and colleagues (2014), a 52-week trial of 60 men aged 60 or older with low testosterone given testosterone enanthate 125 mg/wk or vehicle with finasteride 5 mg/day or placebo, where finasteride completely prevented testosterone's 11.4 cm3 rise in prostate volume.123
Tablet strengths and label doses
The table is set at the top of the page
The Propecia label describes its tablets as 1 mg and the Proscar label as 5 mg, both film-coated tablets for oral administration, and both labels allow them with or without meals.12
The Propecia patient information says that if a dose is forgotten, no extra tablet is taken.1 The same label says that, in general, daily use for three months or more is necessary before benefit is observed, and that withdrawal of treatment leads to reversal of effect within 12 months.1
Finasteride with testosterone or a steroid cycle
The closest trial is Borst and colleagues (2014), a 52-week randomised 2 x 2 factorial trial of 60 men aged 60 or older with low testosterone, in which testosterone enanthate 125 mg/wk or vehicle was paired with finasteride 5 mg/day or placebo.3 In that trial testosterone raised upper and lower body muscle strength by 8-14%, fat-free mass by 4.04 kg, lumbar spine bone mineral density by 4.19% and total hip bone mineral density by 1.96% over 12 mo, reduced total body fat by 3.87 kg and trunk fat by 1.88 kg, and raised hematocrit by 4.13% in the first 3 mo; finasteride did not alter any of these effects, and it completely prevented testosterone's 11.4 cm3 rise in prostate volume.3 The authors call that testosterone dose higher-than-replacement and describe the men as older hypogonadal men; the searches found no trial of finasteride during a bodybuilding or performance steroid cycle.3
What trials used
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Kaufman 1998 (hair loss) | Oral finasteride 1 mg/d or placebo | 1553 men aged 18 to 41; 1215 continued in blinded extension studies for a second year4 | Two 1-year trials, blinded second-year extension |
| Olsen 2006 (hair loss) | Dutasteride 0.05, 0.1, 0.5 or 2.5 mg, finasteride 5 mg, or placebo daily | Four hundred sixteen men5 | 24 weeks |
| Thompson 2003 (PCPT) | Finasteride 5 mg per day or placebo | 18,882 men aged 55 or older with a normal digital rectal examination and PSA of 3.0 ng per milliliter or lower6 | Seven years |
Crushed tablets and topical mixes
The Propecia label cautions women who are or may potentially be pregnant against handling crushed or broken tablets because of a potential risk to a male fetus, and says the coated tablets prevent contact with the active ingredient during normal handling, provided that the tablets are not broken or crushed.1 The Proscar label gives the same warning for females who are or may be pregnant.2 Searches found no US label for a topical finasteride solution and no instructions for mixing crushed tablets into minoxidil or any liquid. They did find one DailyMed listing, Johnson Foam Pro, which names a finasteride 0.25% foam with 5% minoxidil for use by men only; the saved listing has no dosing or storage text.7 They also found no label or maker's leaflet for crushing or dissolving tablets, and no stability data for a mixed or topical preparation.
Storage
The Propecia label gives room temperature, 15-30°C, with the container closed and protected from moisture.1 The Proscar label gives below 30°C, protected from light, with the container tightly closed.2
Frequently asked questions
What do Milligram users log for finasteride?
Finasteride is not in the logged figures the app can show.
Does finasteride lower PSA?
The Propecia label says mean PSA fell from 0.7 ng/mL at baseline to 0.5 ng/mL at month 12 on 1 mg in men 18-41 years of age, and by approximately 50% on 5 mg in older men with BPH.1 The label adds that these findings are to be taken into account when reading PSA in men on finasteride, and that any confirmed increase from the lowest PSA value on Propecia may signal the presence of prostate cancer and is to be evaluated, even within the normal range.1
Is finasteride on the WADA prohibited list?
The text of the WADA 2026 Prohibited List names neither finasteride nor dutasteride, so it gives no statement about finasteride either way.8
Is there a finasteride label dose for women?
The Propecia label limits its indication to men only and contraindicates finasteride in women who are or may potentially be pregnant; it reports that in a 12-month study of 137 postmenopausal women with androgenetic alopecia (67 on Propecia, 70 on placebo) effectiveness could not be demonstrated, and the searches found no female dose in a label or in the other saved trials.1
References
- DailyMed (FDA label). These highlights do not include all the information needed to use PROPECIA safely and effectively. See full prescribing information for PROPECIA. PROPECIA ® (finasteride) tablets for oral use Initial U.S. Approval: 1992. 2024. dailymed.nlm.nih.gov
- DailyMed (FDA label). These highlights do not include all the information needed to use PROSCAR safely and effectively. See full prescribing information for PROSCAR. PROSCAR ® (finasteride) Tablets Initial U.S. Approval: 1992. 2026. dailymed.nlm.nih.gov
- PubMed. Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial. 2014. pubmed.ncbi.nlm.nih.gov
- PubMed. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. 1998. pubmed.ncbi.nlm.nih.gov
- PubMed. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. 2006. pubmed.ncbi.nlm.nih.gov
- PubMed. The influence of finasteride on the development of prostate cancer. 2003. pubmed.ncbi.nlm.nih.gov
- DailyMed (FDA label). 84539-002 JOHNSON FOAM PRO. 2026. dailymed.nlm.nih.gov
- WADA. WORLD ANTI-DOPING CODE. wada-ama.org